Solution conformation by NMR and molecular modeling of three sulfide-free somatostatin octapeptide analogs compared to angiopeptin.
The conformation in dimethylsulfoxide of the somatostatin derivative angiopeptin and of three disulfide-free analogs was estimated by two-dimensional nuclear magnetic resonance spectroscopy at room temperature. The resulting 3D molecular graphics were compared and shown to reflect the observed differences in the inhibition of restenosis after rat aorta balloon injury by these octapeptide inhibitors. Angiopeptin and its active analog 2 displayed a relatively rigid conformation of the cyclic hexapeptide backbone due to the presence of two well-defined hydrogen bonds, further stabilized by a third hydrogen bond outside the ring. No such constraints were detected for the two biologically inactive analogs, which, compared to 2, had a two-atom longer or shorter hexapeptide ring. The well-defined structure of compound 2 may serve as an improved pharmacophore for this new class of drugs.
Hennig
P
P
Institut de Recherches Servier, Suresnes, France.
Raimbaud
E
E
Thurieau
C
C
Volland
J P
JP
Michel
A
A
Fauchère
J L
JL
D000595:Amino Acid Sequence; D000818:Animals; D001024:Aortic Valve Stenosis / Q000517:prevention & control; D002317:Cardiovascular Agents / Q000737:chemistry / Q000494:pharmacology; D003198:Computer Simulation; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009842:Oligopeptides / Q000737:chemistry* / Q000494:pharmacology; D010456:Peptides, Cyclic; D011487:Protein Conformation; D051381:Rats; D012996:Solutions; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology
D002317:Cardiovascular Agents; D009842:Oligopeptides; D010456:Peptides, Cyclic; D012996:Solutions; C060347:lanreotide; D013004:Somatostatin